Abstract:BackgroundBombesin Receptor Subtype-3 (BRS-3, Bombesin-like receptor, BB3) is an orphan G-protein coupled receptor (GPCR). Recent studies have shown that BRS-3 played a vital role in glucose regulation, insulin secretion, and energy homeostasis. Therefore, discovering more novel exogenous ligands with diverse structures for BRS-3 will be of great importance for target validation and drug development.PurposeIn this study, we aim to discover new agonists of BRS-3 from our natural compound libraries, providing a new probe to study the function of BRS-3.Study designMultiple cell-based assays and in vivo experiments were performed to identify the new ligand.MethodsBRS-3 overexpression cells were coupled with FLIPR assay, homogeneous time-resolved fluorescence (HTRF) IP-ONE assay, dynamic mass redistribution (DMR) assay, β-arrestin2 recruitment assay, and western blot to determine receptor activation and downstream signaling events. To further validate the target of BRS-3, a series of in vitro and in vivo experiences were conducted, including glucose uptake, glucose transporter type 4 (GLUT4) transportation in C2C12, and oral glucose tolerance test (OGTT) in mice.ResultsWe discovered and identified oridonin as a novel small molecule agonist of BRS-3, with a moderate affinity (EC50 of 2.236 × 10−7 M in calcium mobilization assay), specificity, and subtype selectivity. Further in vitro and in vivo tests demonstrated that oridonin exerted beneficial effects in glucose homeostasis through activating BRS-3.ConclusionsOridonin, as the discovered new ligand of BRS-3, provides a valuable tool compound to investigate BRS-3′s function, especially for target validation in type 2 diabetes and obesity. Oridonin is promising as a lead compound in the treatment of metabolic disorders. Compared to the known agonists of BRS-3, we can take advantage of the multiple reported pharmacological activities of ODN as a natural product and assess whether these pharmacological activities are regulated by BRS-3. This may facilitate the discovery of novel functions of BRS-3.

Pharmacological Characterization of a Selective Agonist for Bombesin Receptor Subtype-3

Bombesin Receptor Subtype-3 in Human Diseases

A Selective Human Bombesin Receptor Subtype-3 Peptide Agonist Mediates CREB Phosphorylation and Transactivation.

Receptor-specific crosstalk between prostanoid E receptor 3 and bombesin receptor subtype 3

Structural insights into ligand recognition, selectivity, and activation of bombesin receptor subtype-3

[Discovery of exogenous ligands for orphan receptor BRS-3 from Chinese herbs].

A Selective Bombesin Receptor Subtype 3 Agonist Promotes Weight Loss in Diet-Induced–Obese Rats With Circadian Rhythm Change

Discovery of oridonin as a novel agonist for BRS-3

Structures of Human Gastrin-Releasing Peptide Receptors Bound to Antagonist and Agonist for Cancer and Itch Therapy.

Bombesin-like Receptor 3 (brs3) Expression in Glutamatergic, but Not GABAergic, Neurons is Required for Regulation of Energy Metabolism.

Discovery of Dimethyl Shikonin Oxime 5a, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Type 2 Diabetes Mellitus

Proteomics Analysis of Cellular BRS3 Receptor Activation Reveals Potential Mechanism for Signal Transduction and Cell Proliferation

Identification and Functional Characterization of Two Orphan G-protein-coupled Receptors for Adipokinetic Hormones from Silkworm Bombyx mori

Constitutively Active BRS3 is a Genuinely Orphan GPCR in Placental Mammals

Bombesin-like peptides and their receptors: recent findings in pharmacology and physiology.

Bombesin-like Peptides and Their Receptors

Molecular and Functional Characterization of Adipokinetic Hormone Receptor and Its Peptide Ligands in Bombyx Mori

A Comparative Study of Radiolabeled Bombesin Analogs for the PET Imaging of Prostate Cancer.

Novel Agonist Bioisosteres and Common Structure-Activity Relationships for The Orphan G Protein-Coupled Receptor GPR139

Molecular Recognition of Itching Neuropeptides by Bombesin Receptors

Extraintestinal Roles of Bombesin-Like Peptides and Their Receptors